Sun Yat-sen University

Founded in 1924 by Dr. Sun Yat-sen, a great national hero, patriot, and pioneer of China's democratic revolution, and co-established by early leaders of the Chinese Communist Party, Sun Yat-sen University is one of the birthplaces of Marxism in China. It carries a legacy of revolutionary tradition, patriotic dedication, and excellence. Originally named National Guangdong University, it was renamed National Sun Yat-sen University in 1926 following Dr. Sun’s death. Today’s university merged from two institutions—the original Sun Yat-sen University and Zhongshan Medical University—in October 2001. Under the leadership of the Communist Party of China and with support from the Ministry of Education, Guangdong Province, and local governments in Guangzhou, Shenzhen, and Zhuhai, Sun Yat-sen University upholds its comprehensive, research-oriented, and open educational philosophy to accelerate its development into a world-class university with Chinese characteristics.

South China University of Technology

Located in Guangzhou, South China University of Technology (SCUT) is a key national university directly under the Ministry of Education. Its campuses include Wushan, University Town, and Guangzhou International Campus, earning it the title of "National Civilized Campus." With roots tracing back to 1918 as Guangdong Provincial First Higher Industrial School ("Red Industry School"), SCUT was formally established in 1952 during China’s national higher education restructuring as one of the "Four Great Engineering Universities" of New China. It became a key national university in 1960, gained doctoral and master’s degree authorization in 1981, pioneered provincial-ministerial co-construction in 1993, joined the "211 Project" in 1995, the "985 Project" in 2001, and the "Double First-Class" initiative in 2017. In 2023, it ranked among the top 150 universities globally in the ShanghaiRanking’s Academic Ranking of World Universities.

Southern Medical University

Originally founded in 1951 as the PLA First Military Medical University, Southern Medical University was designated a key national university in 1979. Relocated to Guangdong Province in 2004 and renamed Southern Medical University, it operates campuses in Guangzhou and Shunde. As the sole medical university among Guangdong’s first batch of provincial high-level universities, it is a national pioneer in "ministry-province co-construction" for medical education. The university was among the first eight institutions nationwide to offer an eight-year clinical medicine program (MD-PhD) and a pilot program for elite physician training. In 2024, it entered the top 300 of the Times Higher Education World University Rankings.

Huawei Technologies Co., Ltd.

Founded in 1987, Huawei Technologies Co., Ltd. is a global leading provider of ICT (Information and Communication Technology) infrastructure and smart devices. Currently, Huawei has 208,000 employees, its business spans more than 170 countries and regions, and serves a global population of over 3 billion.

Huawei is committed to bringing the digital world to everyone, every family, and every organization, and building a smart world where everything is interconnected. Ubiquitous connectivity should be an equal right for all and the prerequisite and foundation of the smart world. It provides diverse computing power to the world, makes the cloud ubiquitous and intelligence accessible everywhere. All industries and organizations become agile, efficient, and vibrant thanks to powerful digital platforms. By redefining experiences through AI, consumers can enjoy ultimate personalized smart experiences in all scenarios such as home, travel, office, audio - visual entertainment, and sports and health.

China Mobile Group Guangdong Co., Ltd.​

China Mobile Group Guangdong Co., Ltd.​ (abbreviated as "Guangdong Mobile"), a subsidiary of China Mobile Communications Group Co., Ltd., is a backbone enterprise in the information and communication field of Guangdong Province and a core force in the development of the digital economy. As a key practitioner of China Mobile's vision to become a "world-class technology service enterprise," Guangdong Mobile adheres to the principles of focusing on the forefront of global science and technology, the main battlefield of the economy, major national needs, and the better life of the people. It strives to build high-speed, intelligent, and secure information and communication infrastructure, create a digital intelligence service ecosystem, and assist Guangdong in accelerating digital intelligence transformation and achieving high-quality development.

Guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, Guangdong Mobile thoroughly implements the deployments of the Guangdong Provincial Party Committee and Government and China Mobile Group Corporation. It actively integrates into the construction of the Guangzhou-Hong Kong-Macao Greater Bay Area, anchors the digital economy development strategy, and leverages the resources of 30 professional companies under China Mobile and the upstream and downstream of the industrial chain to unleash the potential of technologies such as computing power, big data, and artificial intelligence. Through 5G+AI, it empowers various industries. In 2025, Guangdong Mobile achieved a main business revenue of over 115 billion yuan, completed investments of over 14 billion yuan, and paid taxes of approximately 13 billion yuan. Its revenue, customers, network scale, and service level all remain industry-leading. Recently, it has launched multiple benchmark applications represented by 5G emergency rescue, quantum + biomedicine, and embodied artificial intelligence, and has won numerous honors such as the Benchmark Enterprise of the State-owned Assets Supervision and Administration Commission and the Advanced Collective of Guangdong Province in Poverty Alleviation. Upholding the original intention of "People's Posts and Telecommunications for the People," it injects strong momentum into the implementation of the national digital strategy and the local economic and social development.

Guangdong Hengdian Information Technology Co., Ltd.

Guangdong Hengdian Information Technology Co., Ltd. (stock name: Hengdian Technology; stock code: 839033) is a “Little Giant” enterprise specializing in niche, specialized, distinctive, and innovative technologies at the national level, with R&D and services of high - tech products as its core business. Its main products cover a wide range, including the Heterogeneous Computing Power Intelligent Management Platform, AI General Education Platform, AIGC IoT Management and Control Platform, Low - Code Development Software for Industrial Applications, Industrial Data Analysis Software, Industrial Virtual Simulation Commissioning Software, Intelligent Equipment System, iDLP Deep Learning Platform, Medical Imaging Assisted Diagnosis Platform, Criminal Risk Assessment System, Educational Reform System, Smart Campus Solution, and talent cultivation solutions for cloud computing/big data/AI/industrial software in higher education institutions. The company continuously rolls out new products. It has formed a professional one - stop service chain that encompasses information consultation, technology R&D, project implementation, technical support, and operation & maintenance services.

As the supporting entity of the Guangdong Provincial Engineering Technology Research Center for Education Cloud PaaS Platform, the company has taken the lead or jointly established multiple provincial - level engineering technology research centers with many universities and research institutions in fields such as smart vocational education, data security, big data for precision medicine in traditional Chinese medicine, and big data on online public opinion. After more than a decade of stable operation and profound accumulation, the company has accumulated hundreds of successful service cases in artificial intelligence, industrial software, cloud computing, big data, overall informatization solutions for smart campuses, system integration, and engineering construction, along with rich practical experience, and owns multiple intellectual property rights. In recent years, the company has continuously increased R&D investment in artificial intelligence, big data, and cloud computing systems. At the same time, it attaches great importance to cooperation with renowned research institutions at home and abroad. Through the “R&D + Products + Services” operation model, it constantly enhances its market competitiveness. Currently, the company has achieved remarkable results in informatization construction projects in industries like smart education, government affairs, healthcare, and manufacturing, winning the trust of numerous users.

Guangdong Bioinformatics Society

Established in 2016 with the approval of the Guangdong Provincial Department of Civil Affairs, the Guangdong Bioinformatics Society aims to unite bioinformatics workers, cultivate and attract high-level bioinformatics talents, promote the application of bioinformatics, drive the development of bioinformatics, expand the influence of bioinformatics in Guangdong Province, and contribute to the economic construction of Guangdong Province. The first Council was chaired by Professor Xie Zhi from the Zhongshan Ophthalmic Center of Sun Yat-sen University, with Professor Rao Shaoqi (Guangdong Medical University), Professor Zhang Zhenhai (Southern Medical University), and Professor He Xionglei (Sun Yat-sen University) serving as vice-chairmen.

In May 2023, the Guangdong Bioinformatics Society successfully completed the Council election, and the second Council was chaired by Professor Xie Zhi from the Zhongshan Ophthalmic Center of Sun Yat-sen University, with Professor Zhou Tianshou (Sun Yat-sen University), Professor Cai Hongmin (South China University of Technology), Professor Chen Wei (Southern University of Science and Technology), Director Jing Ruifeng (Guangzhou Laboratory), Professor Li Jinyan (Shenzhen University of Technology), Executive Director Xu Xun (Huada Research Institute), and Professor Gu Zhenglong (Guangdong-Hong Kong-Macao Precision Medicine Research Institute) serving as vice-chairmen. Meanwhile, multiple units including Sun Yat-sen University, Guangdong Medical University, Southern Medical University, Shantou University, Harbin Institute of Technology, and Southern University of Science and Technology formed the Council and Standing Council units, with many academic leaders and professors becoming members of the Council.

BGI Research

As the core R&D arm of BGI Group, the Shenzhen Institute of Life Sciences focuses on life sciences and biotechnology to advance global health. Its research centers on genomic technologies and cutting-edge scientific challenges, driving innovations in human health and disease understanding.

CloudNa

Launched in 2018 by alumni of the Chinese Academy of Sciences and Peking Union Medical College, CloudNa (www.cloudna.cn) is an AI-driven life science enterprise with headquarters in Beijing and regional hubs in Guangzhou, Changsha, Suzhou, and Chengdu. Specializing in translational medicine and bio-intelligence, CloudNa leverages its BT-IT development engine to create AI-powered platforms for clinical cohorts, omics research, public health, diagnostics, and drug design. Collaborating with 8 national clinical centers and 24 top-tier hospitals, it delivers end-to-end data solutions for life science research, pioneering AI-driven paradigms in the field.

Genomics Communications (gComm)

Genomics Communications (gComm) is an open-access, peer-reviewed journal launched in August 2024 by Maximum Academic Press. Edited by Professor Wu Zhiqiang of the Chinese Academy of Agricultural Sciences, it publishes original research, reviews, letters, perspectives, and commentaries in functional, quantitative, comparative, and computational genomics; genome editing; AI applications in genomics; and laboratory technologies. Committed to fostering global academic exchange, gComm offers free article publication from 2024 to 2026. Visit the journal website at https://www.maxapress.com/gcomm.

OPENI

Openi is an open-source AI platform and community jointly established by the New Generation Artificial Intelligence Industry Technology Innovation Strategic Alliance (AITISA)​ under the national strategy for developing next-generation AI technologies. It brings together leading academic institutions such as Pengcheng Laboratory, Beijing Academy of Artificial Intelligence (BAAI), Peking University, and the National University of Defense Technology, as well as top-tier enterprises like Huawei, Baidu, and Megvii in the AI field. Guided by the principles of "open source and openness, respecting innovation," the community aims to build a globally influential open-source AI platform and ecosystem​ that fosters collaboration, innovation, and sustainable development in the field of artificial intelligence.

Sino Biological, Inc

Sino Biological, Inc. (hereinafter referred to as "Sino Biological") is a leading domestic expert in the research, development, and production of proteins and antibodies in China. It focuses on providing comprehensive, high-quality recombinant proteins, antibodies, and other biological reagents, as well as professional, one-stop technical services for life science research and innovative drug development. Headquartered in Beijing, the company is a national high-tech enterprise listed on the ChiNext Board of the Shenzhen Stock Exchange in August 2021 (stock code: 301047).

Sino Biological has mastered a full set of key technologies for innovative research and development of biological reagents centered on proteins and antibodies, along with five core technology platforms. It offers over 9,800 types of recombinant proteins, more than 15,000 types of antibodies, over 50,000 types of genes, and a series of high-performance serum-free culture media products. The company has established a one-stop biological reagent and technical service platform covering gene cloning, protein expression, antibody development and production, as well as biological analysis and detection. With its own R&D and production center spanning over 20,000 square meters, a clean production workshop of over 5,000 square meters, advanced instruments and equipment worth over 100 million yuan, and a 4,000-liter culture media production line, Sino Biological ensures efficient and high-quality output. The company has a rigorous quality control and testing technology platform, having obtained certifications such as ISO 9001, ISO 13485, CNAS, CMA, and GMP compliance certification.

Sino Biological is committed to addressing the "necklace" problem of core technologies in the biological reagent field, building China's own national brand of biological reagents, and helping promote the development of health undertakings and benefit humanity.

Xiamen Fuchen Bio-Technology Co., Ltd.

Xiamen Fuchen Bio-Technology Co., Ltd. is a National High-tech Enterprise specializing in the development of nanobodies. The core team began exploring shark nanobodies as early as 2016, making it one of the first domestic teams to engage in this field, and has established an industry-leading shark nanobody technology platform. The company pioneered a three-dimensional shark farming platform, achieving large-scale artificial shark breeding and solving the longstanding challenge of screening natural shark-derived nanobodies. It has built a full-process R&D, production, and application system for nanobodies. The company’s service offerings include custom nanobody development, protein expression and purification, optimization of prokaryotic/yeast small-scale fermentation processes, and more.